81 related articles for article (PubMed ID: 2953804)
1. Granulocyte-monocyte colony-stimulating-factor augments the interleukin-2-induced cytotoxic activity of human lymphocytes in the absence and presence of mouse or chimeric monoclonal antibodies (mAb 17-1A).
Masucci G; Ragnhammar P; Wersäll P; Mellstedt H
Cancer Immunol Immunother; 1990; 31(4):231-5. PubMed ID: 2199042
[TBL] [Abstract][Full Text] [Related]
2. Effects of colony-stimulating factors on cellular cytotoxicity.
Durek C; Schäfer I; Braasch H; Ulmer AJ; Ernst M; Flad HD; Jocham D; Böhle A
Cancer Immunol Immunother; 1997 Mar; 44(1):35-40. PubMed ID: 9111582
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of interleukin-35 receptor distinguishes different subsets of granulocyte-macrophage-colony-stimulating factor-producing T helper cells in a mouse endometriosis model.
Lin F; Yu H; Zhang L; Zhou J; Cao Y; Wu S; Wang J
Mol Immunol; 2023 Dec; 164():28-38. PubMed ID: 37944204
[TBL] [Abstract][Full Text] [Related]
4. The Mechanistic Target of Rapamycin Complex 1 Pathway Contributes to the Anti-Tumor Effect of Granulocyte-Macrophage-Colony-Stimulating Factor-Producing T Helper Cells in Mouse Colorectal Cancer.
Zhou H; Jiang B; Qian Y; Ke C
Immunol Invest; 2024 Feb; 53(2):261-280. PubMed ID: 38050895
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck.
Yasumura S; Amoscato A; Hirabayashi H; Lin WC; Whiteside TL
Cancer Immunol Immunother; 1994 Dec; 39(6):407-15. PubMed ID: 8001029
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the immune response to tumors by a novel synthetic compound, (4R)-3-benzoyl-N-[(1R)-1-phenylethyl]-4-thiazolidinecarboxamide (RS-0481).
Kurakata S; Tomatsu M; Arai M; Arai H; Hishinuma A; Kohno H; Kitamura K; Kobayashi T; Nomoto K
Cancer Immunol Immunother; 1991; 33(2):71-9. PubMed ID: 1828007
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel marker for human granulocytes and tissue macrophages: RTL1 revisited.
Mortezagholi S; Mahmoudi AR; Shojaeian S; Vafaei S; Soltanghoraei H; Bayat AA; Shokri F; Ghods R; Zarnani AH
Cell Tissue Res; 2023 Oct; 394(1):177-188. PubMed ID: 37535101
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of sea bass (Dicentrarchus labrax L.) recombinant interleukin-1beta.
Buonocore F; Forlenza M; Randelli E; Benedetti S; Bossù P; Meloni S; Secombes CJ; Mazzini M; Scapigliati G
Mar Biotechnol (NY); 2005; 7(6):609-17. PubMed ID: 16059754
[TBL] [Abstract][Full Text] [Related]
9. Local expression of antiinflammatory cytokines in cancer.
Yamamura M; Modlin RL; Ohmen JD; Moy RL
J Clin Invest; 1993 Mar; 91(3):1005-10. PubMed ID: 8450029
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells.
van den Bosch G; Preijers F; Vreugdenhil A; Hendriks J; Maas F; De Witte T
Clin Exp Immunol; 1995 Sep; 101(3):515-20. PubMed ID: 7664499
[TBL] [Abstract][Full Text] [Related]
11. The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma.
Steger GG; Kaboo R; deKernion JB; Figlin R; Belldegrun A
Br J Cancer; 1995 Jul; 72(1):101-7. PubMed ID: 7599037
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.
Uyttenhove C; Simpson RJ; Van Snick J
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6934-8. PubMed ID: 3137580
[TBL] [Abstract][Full Text] [Related]
13. Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432.
Aiba S; Tagami H
Arch Dermatol Res; 1989; 281(5):310-5. PubMed ID: 2679407
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor.
Horowitz MC; Coleman DL; Flood PM; Kupper TS; Jilka RL
J Clin Invest; 1989 Jan; 83(1):149-57. PubMed ID: 2642917
[TBL] [Abstract][Full Text] [Related]
15. Binding properties and proliferative effects of human recombinant granulocyte-macrophage colony-stimulating factor in primary leukemia and lymphoma.
Piao YF; Chiba S; Tojo A; Urabe A; Nara N; Miyazono K; Takaku F
Jpn J Cancer Res; 1989 Sep; 80(9):887-94. PubMed ID: 2557316
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.
Kupper TS; Lee F; Birchall N; Clark S; Dower S
J Clin Invest; 1988 Nov; 82(5):1787-92. PubMed ID: 2460504
[TBL] [Abstract][Full Text] [Related]
17. Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.
Friedman AM; Ptak W; Brewer E; Green DR; Reuter PA; Flood PM
Immunology; 1990 Oct; 71(2):282-9. PubMed ID: 1699882
[TBL] [Abstract][Full Text] [Related]
18. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
Kupper T; Flood P; Coleman D; Horowitz M
J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804
[TBL] [Abstract][Full Text] [Related]
19. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
Kupper T; Horowitz M; Lee F; Robb R; Flood PM
J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
